TheraP: Lu-177-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-Overall survival after median follow-up of 3 years (ANZUP 1603).

Michael S. Hofman; Louise Emmett; Shahneen Sandhu; Amir Iravani; Anthony M. Joshua; Jeffrey C. Goh; David A. Pattison; Thean Hsiang Tan; Ian D. Kirkwood; Roslyn J. Francis; Craig Gedye; Natalie K. Rutherford; Alison Yan Zhang; Margaret Mary McJannett; Martin R. Stockler; Scott Williams; Andrew James Martin; Ian D. Davis

TheraP: Lu-177-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-Overall survival after median follow-up of 3 years (ANZUP 1603).

Michael S. Hofman, Louise Emmett, Shahneen Sandhu, Amir Iravani, Anthony M. Joshua, Jeffrey C. Goh, David A. Pattison, Thean Hsiang Tan, Ian D. Kirkwood, Roslyn J. Francis, Craig Gedye, Natalie K. Rutherford, Alison Yan Zhang, Margaret Mary McJannett, Martin R. Stockler, Scott Williams, Andrew James Martin, Ian D. Davis

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

41 Citations (Web of Science)

Original language	English
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	40
Issue number	16
Publication status	Published - 1 Jun 2022
Externally published	Yes
Event	Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States Duration: 3 Jun 2022 → 7 Jun 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Hofman, M. S., Emmett, L., Sandhu, S., Iravani, A., Joshua, A. M., Goh, J. C., Pattison, D. A., Tan, T. H., Kirkwood, I. D., Francis, R. J., Gedye, C., Rutherford, N. K., Zhang, A. Y., McJannett, M. M., Stockler, M. R., Williams, S., Martin, A. J., & Davis, I. D. (2022). TheraP: Lu-177-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-Overall survival after median follow-up of 3 years (ANZUP 1603). Journal of Clinical Oncology, 40(16).

@article{6b9a9255a0a14b34994637f504ba543f,

title = "TheraP: Lu-177-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-Overall survival after median follow-up of 3 years (ANZUP 1603).",

author = "Hofman, {Michael S.} and Louise Emmett and Shahneen Sandhu and Amir Iravani and Joshua, {Anthony M.} and Goh, {Jeffrey C.} and Pattison, {David A.} and Tan, {Thean Hsiang} and Kirkwood, {Ian D.} and Francis, {Roslyn J.} and Craig Gedye and Rutherford, {Natalie K.} and Zhang, {Alison Yan} and McJannett, {Margaret Mary} and Stockler, {Martin R.} and Scott Williams and Martin, {Andrew James} and Davis, {Ian D.}",

year = "2022",

month = jun,

day = "1",

language = "English",

volume = "40",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "16",

note = "Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ASCO ; Conference date: 03-06-2022 Through 07-06-2022",

}

Hofman, MS, Emmett, L, Sandhu, S, Iravani, A, Joshua, AM, Goh, JC, Pattison, DA, Tan, TH, Kirkwood, ID, Francis, RJ, Gedye, C, Rutherford, NK, Zhang, AY, McJannett, MM, Stockler, MR, Williams, S, Martin, AJ & Davis, ID 2022, 'TheraP: Lu-177-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-Overall survival after median follow-up of 3 years (ANZUP 1603).', Journal of Clinical Oncology, vol. 40, no. 16.

TheraP: Lu-177-PSMA-617 (LuPSMA) versus cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-Overall survival after median follow-up of 3 years (ANZUP 1603). / Hofman, Michael S.; Emmett, Louise; Sandhu, Shahneen et al.
In: Journal of Clinical Oncology, Vol. 40, No. 16, 01.06.2022.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - TheraP

T2 - Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

AU - Hofman, Michael S.

AU - Emmett, Louise

AU - Sandhu, Shahneen

AU - Iravani, Amir

AU - Joshua, Anthony M.

AU - Goh, Jeffrey C.

AU - Pattison, David A.

AU - Tan, Thean Hsiang

AU - Kirkwood, Ian D.

AU - Francis, Roslyn J.

AU - Gedye, Craig

AU - Rutherford, Natalie K.

AU - Zhang, Alison Yan

AU - McJannett, Margaret Mary

AU - Stockler, Martin R.

AU - Williams, Scott

AU - Martin, Andrew James

AU - Davis, Ian D.

PY - 2022/6/1

Y1 - 2022/6/1

M3 - Abstract/Meeting Abstract

SN - 0732-183X

VL - 40

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16

Y2 - 3 June 2022 through 7 June 2022

ER -